| Literature DB >> 65572 |
Abstract
All available colloid volume substitutes carry the risk of anaphylactoid reactions. In a multicentre prospective trial, 69 cases of anaphylactoid reactions have been observed among 200 906 infusions of colloid volume substitutes. The frequency of severe reactions (shock, cardiac and/or respiratory arrest) was 0-003% for plasma-protein solutions, 0-006% for hydroxyethyl starch, 0-008% for dextran, and 0-038% for gelatin solutions.Entities:
Mesh:
Substances:
Year: 1977 PMID: 65572 DOI: 10.1016/s0140-6736(77)91953-5
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321